Noninvasive, Multimodal Inflammatory Biomarker Discovery for Systemic Inflammation (NOVA Study): Protocol for a Cross-Sectional Study
Jinjoo Shim, Sinziana Muraru, Rucsandra Dobrota, Elgar Fleisch, Oliver Distler, Filipe Barata, Tiffany Leung, Arish Mudra Rakshasa-Loots · 2024
Read Noninvasive, Multimodal Inflammatory Biomarker Discovery for Systemic Inflammation (NOVA Study): Protocol for a Cross-Sectional Study by Jinjoo Shim, Sinziana Muraru, Rucsandra Dobrota, Elgar Fleisch, Oliver Distler, Filipe Barata, Tiffany Leung, Arish Mudra Rakshasa-Loots (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11576606.txt.
Description
Shim and co-authors set out a protocol, published in 2024, for a study hunting inflammation signals that can be measured without needles. Long-lasting body-wide inflammation drives many chronic diseases. Tracking it today means blood draws, which burden patients and clinics. The team proposes combining several noninvasive sources: signals from skin, breath, saliva, and wearables. Their cross-sectional study will compare each against blood markers, the gold standard.
If some combination tracks blood levels well, daily home monitoring becomes plausible. That could catch flares early and cut clinic visits. The protocol details who will be recruited and how the streams will be fused. It is published ahead of results so the plan is on record. The study's name, NOVA, signals the intended novelty of the approach.
Catalog record
| CREATOR | Jinjoo Shim, Sinziana Muraru, Rucsandra Dobrota, Elgar Fleisch, Oliver Distler, Filipe Barata, Tiffany Leung, Arish Mudra Rakshasa-Loots |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |